SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-063945
Filing Date
2013-08-14
Accepted
2013-08-14 17:43:16
Documents
4
Period of Report
2013-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-18684_18k.htm 8-K 26233
2 EX-99.1 a13-18684_1ex99d1.htm EX-99.1 246561
3 GRAPHIC g186841mm01i001.jpg GRAPHIC 3409
4 GRAPHIC g186841mm01i002.jpg GRAPHIC 2014
  Complete submission text file 0001104659-13-063945.txt   281826
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 131038553
SIC: 2834 Pharmaceutical Preparations